TRCT
SBC

Tower Research Capital (TRC)’s SBC Medical Group SBC Stock Holding History

Tower Research Capital (TRC)’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.8K Buy
5,217
+2,827
+118% +$11.8K ﹤0.01% 3423
2025
Q4 		$10.3K Sell
2,390
-439
-16% -$1.68K ﹤0.01% 3800
2025
Q3 		$12.3K Buy
2,829
+2,815
+20,107% +$12.7K ﹤0.01% 3798
2025
Q2 		$65 Buy
+14
New +$55 ﹤0.01% 5178
2025
Q1 		– Sell
-21
Closed -$117 – 5943
2024
Q4 		$117 Hold
21
– – ﹤0.01% 5449
2024
Q3 		$167 Buy
+21
New +$244 ﹤0.01% 5451

Other funds holding SBC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tower Research Capital (TRC)'s SBC Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its SBC Medical Group (SBC) stake by 118% in Q1 2026, buying an estimated $11.8K and bringing the position to 5,217 shares worth $21.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3423.

Tower Research Capital (TRC) first reported a position in SBC in Q3 2024 and has held it in 6 quarters since. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

  • Tower Research Capital (TRC) held 5,217 shares of SBC Medical Group worth $21.8K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,827 SBC Medical Group shares in Q1 2026, an estimated $11.8K.
  • SBC Medical Group made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3423 holding.
  • Tower Research Capital (TRC) first reported a position in SBC Medical Group in Q3 2024 and has held it in 6 quarters since.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.